If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||
![]() Clinical Microbiology and InfectionVolume 10 Issue 11, Pages 954 - 960 Published Online: 21 Oct 2004 Journal compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases Published on behalf of the European Society of Clinical Microbiology and Infectious Diseases
Abstract | References | Full Text: HTML, PDF (Size: 77K) | Related Articles | Citation Tracking REVIEW Effects of varicella vaccination on herpes zoster incidence Copyright 2004 European Society of Clinical Microbiology and Infectious Diseases KEYWORDS Chickenpox • population models • review • shingles • vaccination • varicella zoster virus Abstract
The effects of a general varicella vaccination programme on the incidence of herpes zoster are of major public health importance. This review focuses on two key aspects, namely the relationship between wild-type virus spread and the incidence of herpes zoster, as obtained from recent surveys, surveillance and observational studies, and the results from mathematical population models. Although knowledge is limited, close contact with varicella cases seems to have a protective effect. Thus, an increase in zoster incidence after varicella immunisation is possible, but the extent is unknown because of the influence of other factors independent of immunisation. Currently, vaccination effects estimated from mathematical modelling depend strongly on pre-specified assumptions. In order to obtain more precise predictions, the results of ongoing monitoring and clinical studies are awaited and further studies are suggested. Vaccination recommendations can be adapted at any time to take account of further findings in this area. Accepted: 6 July 2004 |